ABSTRACT
INTRODUCTION
Parkinson's disease (PD) is named after English Doctor James Parkinson who first identified the condition in 1817 [1] . Today, PD is considered as the second most common neurodegenerative disorder affecting approximately 1% of the human population above the age of 65 [2] . The main symptoms of Parkinson's disease include tremor, slowness of movement and muscle stiffness or rigidity [1] . These symptoms are caused by an insufficient amount of dopamine, a monoamine neurotransmitter in the striatum [3] , due to the death of dopaminergic neuron cells in the substantia nigra [1] . Recent studies revealed that neuron death in the brains of PD patients could be linked to genetic mutation causing abnormal handling of misfolded proteins, increased oxidative stress, mitochondrial dysfunction [4] and inflammation [5] . Collectively, all of these conditions could lead to a new avenue of PD therapy in the future. Meanwhile, administration of levodopa, the dopamine precursor, remains the most popular and effective treatment for PD [6] .
Levodopa is the International Nonproprietary Name of the chemical L-DOPA (L-3, 4-dihydroxy phenylalanine), which is a metabolite with diverse biological functions in humans, animals and some plants. In humans, L-DOPA can cross the blood-brain barrier and be converted to dopamine in the brain. Chemically synthesized L-DOPA is the major ingredient of several prescription drugs used in the therapy of dopamine replacement for PD patients. Although administration of L-DOPA can effectively alleviate the symptoms associated with impaired motor functions and greatly improve the quality of the life of patients with PD, it is compromised by certain serious side effects such as L-DOPA-induced dyskinesia [7] . Alternative sources of L-DOPA have been sought to treat PD. Several research publications [8] [9] [10] [11] and a few anecdotal testimonies [12, 13] have documented the beneficial effects of consuming faba bean or fava bean (Vicia faba L.) seedlings and pods. These reports stimulated interest in using faba bean to improve the quality of life for PD patients. Earlier studies sought various ways to enhance the effectiveness of fava bean sprouts as a treatment for the symptoms of Parkinson's disease [14] [15] [16] ( 
MATERIALS AND METHODS
Used in the current study are six entries including two white flowered NPGS (National Plant Germplasm System) accessions maintained in Pullman, WA, two commercial cultivars with brown and crimson colored flowers, and two breeding lines resulting from a cross between Extra Precoce Violetto, a vegetable type cultivar and Hiverna/2-5EP1, a winter-hardy breeding line from Germany (Table 1) . The extraction of L-DOPA followed the procedure of Shetty et al. [17] , with some modifications. The dried leaf and flower tissues were ground into fine powder with a TissueLyser II (Qiagen, Valencia, CA) at a frequency of 30 Hz for 30 sec. Approximately 100 mg of the powder was taken for L-DOPA extraction with 1 ml acetate buffer pH 4.2 containing, 0.215 mM octyl sulfate, and 0.074 mM NaEDTA. Each sample was filtered through 0.45-μm cellulose acetate filter (Restek, Corp., Bellefonte, PA) before quantification.
L-DOPA was quantified by an ACQUITY UPLC system with a HSS T3 column (Waters, Milford, MA). MS (Mass Spectrometric) analysis was performed on an inline Synapt G2 HDMS time-of-flight mass spectrometer (Waters, Milford, MA). Chromatographic separation and quantification was carried out with the following LC conditions: Column: Waters UPLC HSS T3 column (100Å, 1.8 µm, 2.1 mm X 100 mm); Column temp: 30℃; Mobile phase: A= 0.1% formic acid (FA), 5 L-DOPA was first isolated from faba bean over 100 year ago [18] . After L-DOPA was used to treat Parkinson's disease in the 1970s, researchers examined the distribution of L-DOPA in different plant parts and the metabolic changes during development. These findings determined that L-DOPA is present in several tissues of faba bean [19] , with 9-day old seedlings containing 2% [20] and young pod material containing 6% and 6.75% of L-DOPA [21] , while young developing seeds contain approximately 4% of L-DOPA decreasing to less than 1% at seed maturity [22] . Geng [23] reported that there is substantial variation in L-DOPA content among six organs of the faba bean cultivar 'Qinghai 166': flower, 6.52%; leaf, 5.74%; stem, 1. 99%; pod, 0.03%; seeds, 0.03%; seed coat, 0.025%. Further, Cao [24] reported the L-DOPA content of multiple faba bean cultivars: flowers from 3.99% to 10.18% DW across 197 cultivars; seedlings from 4.39% to 7.64% DW across 32 cultivars; seeds from 0.034% to 0.095% DW across 52 cultivars with green seed coat. The current study analyzed the L-DOPA content in the flower and leaf tissues of six entries with common and rare flower colors and found substantial variation of L-DOPA content which appears to be attributed to both genetic and environmental influence. Faba bean is one of a few plant species that have the potential to be used as a natural source of L-DOPA. Over the years, researchers have gained important knowledge on L-DOPA via the faba bean crop. The following three aspects are highly relevant to using faba bean for PD patients: 1) there is significant variation in L-DOPA concentration among different cultivars or varieties, 2) the distribution of L-DOPA is uneven in various parts (tissues) and varies with developmental stage, and 3) certain adverse growing conditions such as drought also affect the L-DOPA concentration in the plant [22] . Therefore, in order to attain a satisfactory result in using faba bean for alleviating PD symptoms, the first consideration is to choose an appropriate cultivar with adequate L-DOPA content. As a worldwide-grown cool season legume crop, faba bean has relatively rich genetic resources that remain unexplored for L-DOPA content. There are over 43,500 faba bean accessions conserved in 37 national or international genebanks [25] . The second consideration is to use the tissue or organ that contains adequate amounts of L-DOPA to alleviate PD symptoms. The mature dry faba bean seeds may be nutritious but only contain a fraction of the L-DOPA present within young pods, immature bean seeds, flower buds or green leaf tissue.
RESULTS AND DISCUSSION

Conclusions:
Faba bean has the potential to be developed as a functional food crop for PD patients. Consumption of young pods and leaves is the most practical means for direct intake or processing of L-DOPA from the faba bean plant. Favorable environmental conditions for growth will optimize L-DOPA yield [26] . Further analysis of the genetic control of L-DOPA synthesis and metabolism will be valuable, with the possibility of developing environmentally resilient cultivars that can produce desirable amounts of L-DOPA for pharmaceutical use. 
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